Digital Biomarker Market Report 2025 (Global Edition)

Global Digital Biomarker Market Report 2025 Market Size Split by Type (Wearable, Mobile based Applications, Sensors, Others), by Clinical Practice (Neurological Disorders, Respiratory Disease, Others,...

Digital Biomarker Market Report Description

We have various report editions of Digital Biomarker Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Digital Biomarker Market

The competitive landscape of the Digital Biomarker market is characterized by intense competition among a diverse range of players, including healthcare technology companies, biotechnology firms, pharmaceutical companies, and start-ups specializing in digital health solutions. Key players in the market are continually innovating and expanding their product portfolios to stay ahead in the rapidly evolving landscape.

Digital Biomarker Industry News 

In May 2022, a Northern Ireland company called Cumulus Neuroscience began a set of clinical trials to further evaluate the efficiency of their toolkit to track the course of neurodegenerative diseases.

(Source: https://www.prnewswire.com/news-releases/cumulus-neuroscience-commences-clinical-studies-of-digital-biomarker-platform-in-degenerative-neurological-diseases-301554293.html)

In June 2022, Korean Medical Al Company, VUNO, announced the results of its study on digital biomarkers and their impact on detecting liver cancer.

(Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881406/)

Top Companies Market Share in Digital Biomarker Industry: (In no particular order of Rank)

• Abbott
• AliveCor Inc.
• Alphabet Inc.
• Bayer AG
• Biogen Inc.
• Evidation Health Inc.
• Fitbit Inc.
• GlaxoSmithKline Plc.
• Happify Health
• Medopad Ltd
• Mindstrong Health
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Digital Biomarker Market 

Which Region Dominates the Digital Biomarker Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. North America emerges as the dominant region in the Digital Biomarker Market owing to several key factors. Firstly, the region boasts a robust healthcare infrastructure and advanced technological ecosystem, fostering the development and adoption of digital health solutions. With a high prevalence of chronic diseases and an aging population, there is a strong demand for innovative approaches to disease management and remote patient monitoring, driving the uptake of digital biomarkers.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific emerges as the fastest-growing region in the Digital Biomarker Market due to several compelling factors. Firstly, the region's large and diverse population, coupled with rising healthcare expenditure and increasing adoption of digital health technologies, creates a fertile ground for market expansion. With a growing burden of chronic diseases, aging population, and increasing awareness of preventive healthcare, there is a heightened demand for innovative solutions like digital biomarkers to enable early disease detection, personalized healthcare, and remote patient monitoring.

The current report Scope analyzes Digital Biomarker Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Digital Biomarker Market Analysis

According to Cognitive Market Research, the global Digital Biomarker market size was estimated at USD 1751.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 700.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 34.4% from 2024 to 2031. In North America, the Digital Biomarker Market is poised for significant growth, driven by several factors. The region's advanced healthcare infrastructure, coupled with a strong emphasis on technological innovation, positions it as a frontrunner in the adoption of digital health solutions. Within the Digital Biomarker Market, segmentation analysis reveals a diverse range of applications across various healthcare sectors, including neurological disorders, cardiovascular diseases, respiratory diseases, and diabetes management. In conclusion, North America emerges as a dominant force in the Digital Biomarker Market, driven by its robust healthcare infrastructure, technological prowess, and supportive regulatory environment.

Country Analysis

• According to Cognitive Market Research, the US had a major share in the Digital Biomarkers market with a market size of USD 552.68 million in 2024 and is projected to grow at a CAGR of 34.2% during the forecast period. The demand is amplified by the region's advanced healthcare infrastructure propel consistent growth. 
• The Canada Digital Biomarkers market had a market share of USD 84.06 million in 2024 and is projected to grow at a CAGR of 35.2% during the forecast period. Canada's strong emphasis on technological innovation, positions it as a frontrunner in the adoption of digital health solutions.
• The Mexico Digital Biomarkers market is projected to witness growth at a CAGR of 34.9% during the forecast period with a market size of USD 63.74 million in 2024.

 

Europe Digital Biomarker Market Analysis

According to Cognitive Market Research,, the global Digital Biomarker market size was estimated at USD 1751.2 Million out of which Europe market of more than 30% of the global revenue with a market size of USD 525.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 34.7% from 2024 to 2031.the Digital Biomarker Market demonstrates promising growth prospects, propelled by several factors. The region's well-established healthcare system, coupled with a strong focus on research and development, provides a conducive environment for the adoption of digital health technologies. Segmentation analysis of the Digital Biomarker Market in Europe reveals a diverse array of applications across various healthcare domains, including neurological disorders, respiratory diseases, cardiovascular diseases, and diabetes management. In conclusion, Europe emerges as a significant player in the Digital Biomarker Market, driven by its robust healthcare infrastructure, research capabilities, and supportive regulatory environment.

• The United Kingdom Digital Biomarkers market had a market share of USD 88.26million in 2024 and is projected to grow at a CAGR of 35.5% during the forecast period. In the UK, Digital Biomarker sales witness an upswing due to the nation's strong focus on research and development.
• The France Digital Biomarkers market is projected to witness growth at a CAGR of 33.9% during the forecast period with a market size of USD 48.33 million in 2024.
• According to Cognitive Market Research, the Germany Digital Biomarkers market size was valued at USD 104.02 million in 2024 and is projected to grow at a CAGR of 34.9% during the forecast period. In Germany, Digital Biomarker sales surge due to the diverse array of applications across various healthcare domains, including neurological disorders. 
• The Italy Digital Biomarkers market is projected to witness growth at a CAGR of 34.1% during the forecast period with a market size of USD 45.18 million in 2024.
• The Russia Digital Biomarkers market is projected to witness growth at a CAGR of 33.7% during the forecast period with a market size of USD 81.43million in 2024.
• The Spain Digital Biomarkers market is projected to witness growth at a CAGR of 33.8% during the forecast period with a market size of USD 43.08million in 2024.
• The Luxembourg Digital Biomarkers market is projected to witness growth at a CAGR of 34.8% during the forecast period with a market size of USD 16.29million in 2024.
• The Portugal Digital Biomarkers market is projected to witness growth at a CAGR of 34.5% during the forecast period with a market size of USD 11.03million in 2024.
• The Greece Digital Biomarkers market is projected to witness growth at a CAGR of 35.0% during the forecast period with a market size of USD 6.30million in 2024.
• Rest of Europe Digital Biomarkers market is projected to witness growth at a CAGR of 33.4%during the forecast period with a market size of USD 81.43million in 2024.

 

Asia Pacific Digital Biomarker Market Analysis

According to Cognitive Market Research, the global Digital Biomarker market size was estimated at USD 1751.2 Million out of which Asia Pacific held the fastest growing market ofaround23% of the global revenue with a market size of USD 402.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 38.2% from 2024 to 2031.The Digital Biomarker Market shows immense potential for growth, propelled by various factors. Regional analysis indicates a burgeoning healthcare landscape marked by increasing healthcare expenditure, rapid urbanization, and a growing aging population. Segmentation analysis reveals a diverse range of applications for digital biomarkers across different healthcare sectors, including neurological disorders, respiratory diseases, cardiovascular diseases, and diabetes management. In conclusion, the Asia-Pacific region emerges as a key player in the Digital Biomarker Market, driven by its rapidly evolving healthcare landscape, technological advancements, and supportive regulatory environment.

• According to Cognitive Market Research, the China Digital Biomarkers market size was valued at USD 181.25million in 2024 and is projected to grow at a CAGR of 37.7% during the forecast period. Digital Biomarker sales surge in China due to the nation's rapid expansion in biopharmaceuticals.
• The Japan Digital Biomarkers market is projected to witness growth at a CAGR of 36.7% during the forecast period with a market size of USD55.58million in 2024.
• The India Digital Biomarkers market had a market share of USD 48.33million in 2024 and is projected to grow at a CAGR of 40.0% during the forecast period. The demand is augmented by India's increasing focus on precision medicine and its role as a key player in the global pharmaceutical industry.
• The South Korea Digital Biomarkers market is projected to witness growth at a CAGR of 37.3% during the forecast period with a market size of USD 40.28million in 2024.
• The Australia Digital Biomarkers market is projected to witness growth at a CAGR of 37.9%during the forecast period with a market size of USD 20.94million in 2024.
• The South East Asia Digital Biomarkers market is projected to witness growth at a CAGR of 39.2%during the forecast period with a market size of USD 27.79million in 2024.
• The Rest of Asia Pacific Digital Biomarkers market is projected to witness growth at a CAGR of 38.0%during the forecast period with a market size of USD 28.60million in 2024.

 

South America Digital Biomarker Market Analysis

According to Cognitive Market Research, the global Digital Biomarkers market size was estimated at USD 1751.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 87.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 35.6% from 2024 to 2031.The Digital Biomarker Market presents significant opportunities for growth, underpinned by various factors. Regional analysis indicates a growing healthcare sector driven by increasing healthcare spending, improving healthcare infrastructure, and rising awareness of digital health solutions. Segmentation analysis reveals diverse applications of digital biomarkers across different healthcare domains, including neurological disorders, respiratory diseases, cardiovascular diseases, and diabetes management. Latin America is witnessing increasing investments in healthcare technology and innovation, with a growing number of start-ups and technology companies focusing on digital health solutions. In conclusion, Latin America emerges as a promising market for digital biomarkers, driven by its evolving healthcare landscape, technological advancements, and supportive regulatory environment.

• According to Cognitive Market Research, the Brazil Digital Biomarkers market size was valued at USD 37.48million in 2024 and is projected to grow at a CAGR of 36.2% during the forecast period. Digital Biomarker sales flourish in Brazil due to the increasing healthcare spending, improving healthcare infrastructure, and rising awareness of digital health solutions.
• The Argentina Digital Biomarkers market had a market share of USD 14.71million in 2024 and is projected to grow at a CAGR of 36.5% during the forecast period. The demand is augmented by Argentina's rising awareness of digital health solutions.
• The Colombia Digital Biomarkers market is projected to witness growth at a CAGR of 35.4% during the forecast period with a market size of USD 7.79million in 2024.
• The Peru Digital Biomarkers market is projected to witness growth at a CAGR of 35.8% during the forecast period with a market size of USD 7.18million in 2024.
• The Chile Digital Biomarkers market is projected to witness growth at a CAGR of 35.9% during the forecast period with a market size of USD 6.30million in 2024.
• The Rest of Latin America Digital Biomarkers market is projected to witness growth at a CAGR of 34.7% during the forecast period with a market size of USD 14.10 million in 2024.

 

Middle East Digital Biomarker Market Analysis

According to Cognitive Market Research, the global Digital Biomarker market size was estimated at USD 1751.2 Million out of which Middle East and Africa market ofaround 2% of the global revenue with a market size of USD 35.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 35.9% from 2024 to 2031.The Digital Biomarker Market is poised for significant growth, driven by various factors. Regional analysis highlights a rapidly evolving healthcare landscape marked by increasing healthcare expenditure, improving healthcare infrastructure, and growing adoption of digital health solutions. Segmentation analysis reveals a diverse range of applications for digital biomarkers across different healthcare sectors, including neurological disorders, respiratory diseases, cardiovascular diseases, and diabetes management. the MEA region is witnessing increasing investments in healthcare technology and innovation, with a growing number of start-ups and technology companies focusing on digital health solutions. In conclusion, the Middle East and Africa region present promising opportunities for the Digital Biomarker Market, driven by its evolving healthcare landscape, technological advancements, and supportive regulatory environment.

• According to Cognitive Market Research, the GCC Countries Digital Biomarkers market size was valued at USD 14.99 million in 2024 and is projected to grow at a CAGR of 36.7% during the forecast period. Digital Biomarker sales flourish in the GCC Countries due to the rapidly evolving healthcare landscape.
• The Egypt Digital Biomarkers market is projected to witness growth at a CAGR of 36.2% during the forecast period with a market size of USD 3.68 million in 2024.
• The South Africa Digital Biomarkers market is projected to witness growth at a CAGR of 36.9% during the forecast period with a market size of USD 5.53 million in 2024.Digital Biomarker sales flourish in the South Africa due to the increasing healthcare expenditure, improving healthcare infrastructure, and growing adoption of digital health solutions.
• The Turkey Digital Biomarkers market is projected to witness growth at a CAGR of 35.4% during the forecast period with a market size of USD 3.01 million in 2024.
• The Nigeria Digital Biomarkers market is projected to witness growth at a CAGR of 35.0% during the forecast period with a market size of USD 3.68 million in 2024.
• The Rest of MEA Digital Biomarkers market is projected to witness growth at a CAGR of 34.9% during the forecast period with a market size of USD 4.13 million in 2024.

 

Digital Biomarker Market Analysis

Digital Biomarker Type Segment Analysis

According to Cognitive Market Research, the dominating category is Wearable devices. Wearable devices have established dominance due to their widespread adoption among consumers for health and fitness monitoring purposes. These devices, such as smart watches, fitness trackers, and biosensors, offer continuous monitoring of various physiological parameters like heart rate, activity levels, sleep patterns, and more. The convenience, portability, and ease of use of wearable devices make them highly attractive to users, leading to their widespread acceptance and integration into daily life. Additionally, advancements in wearable sensor technology and the incorporation of advanced features like GPS tracking, ECG monitoring, and blood oxygen saturation measurement contribute to their dominance in the market.

The fastest-growing category in the Digital Biomarker Market is Mobile Applications. Mobile applications offer a versatile platform for collecting, analysing, and transmitting health-related data, making them increasingly popular among users and healthcare providers alike. These applications leverage smartphone capabilities such as cameras, accelerometers, and GPS sensors to monitor various health parameters and behaviours. With the growing adoption of smartphones worldwide and the increasing use of mobile health apps for self-monitoring, disease management, and telemedicine, the demand for mobile applications as digital biomarkers is witnessing rapid growth.

• Wearable
• Mobile based Applications
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Digital Biomarker Industry. Request a Free Sample PDF!

According to Cognitive Market Research, the dominating category is Cardiovascular Disease. Cardiovascular diseases (CVDs) are one of the leading causes of mortality worldwide, necessitating effective monitoring and management strategies. Digital biomarkers play a crucial role in the early detection, risk assessment, and management of CVDs by providing real-time data on key physiological parameters such as heart rate variability, blood pressure, and electrocardiogram (ECG) readings. The integration of wearable devices and mobile applications enables continuous monitoring of cardiovascular health, facilitating timely intervention and personalized treatment plans. Moreover, the growing prevalence of lifestyle-related risk factors such as sedentary lifestyles, unhealthy diets, and stress further emphasizes the need for digital biomarkers in managing cardiovascular health, driving the dominance of this category in the market.

The fastest-growing category in the Digital Biomarker Market is Neurological Disorders. Neurological disorders encompass a broad spectrum of conditions affecting the brain, spinal cord, and peripheral nerves, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. Digital biomarkers offer non-invasive and objective measures for assessing neurological function, disease progression, and treatment response, revolutionizing the diagnosis and management of neurological disorders. Wearable devices and mobile applications equipped with sensors capable of tracking gait, tremors, cognitive function, and sleep patterns enable remote monitoring of patients' neurological health, facilitating early detection of symptoms and personalized interventions.

• Neurological Disorders
• Respiratory Disease
• Others
• Cardiovascular Disease
• Diabetes

 

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Digital Biomarker Therapeutic Area Segment Analysis

According to Cognitive Market Research, the dominant category is Monitoring. Monitoring digital biomarkers involves the continuous tracking of physiological, behavioral, or biological data using digital devices. This category is dominant due to the increasing emphasis on preventive healthcare and the growing adoption of wearable devices and mobile health apps. Monitoring digital biomarkers allows for real-time health tracking, early detection of health issues, and personalized healthcare interventions, which are highly valued by healthcare providers and patients alike.

The fastest-growing category in the Digital Biomarker market is Diagnostic. Diagnostic digital biomarkers are used to detect, confirm, or rule out specific diseases or conditions. This category is experiencing rapid growth due to advancements in technology, such as artificial intelligence and machine learning, which have improved the accuracy and reliability of diagnostic biomarkers.

• Monitoring
• Diagnostic
• Prognostic

Digital Biomarker End-Use Segment Analysis

According to Cognitive Market Research, the dominating category is Healthcare Providers. Healthcare providers, including hospitals, clinics, and research institutions, represent a significant end-user segment for digital biomarkers. These entities utilize digital biomarkers to monitor patients remotely, track disease progression, and personalize treatment plans. The integration of digital biomarkers into healthcare workflows enables healthcare providers to gather real-time data on patients' health status, facilitating timely intervention, and improving patient outcomes. Moreover, digital biomarkers streamline data collection and analysis processes, enabling healthcare providers to make informed decisions based on objective, quantifiable metrics.

The fastest-growing category in the Digital Biomarker Market is Healthcare Consumers. Healthcare consumers, including individuals, patients, and caregivers, are increasingly taking an active role in managing their health and wellness using digital biomarkers. With the proliferation of wearable devices, mobile health apps, and personal health tracking tools, healthcare consumers have access to a wealth of health-related data at their fingertips. Digital biomarkers empower individuals to monitor their vital signs, track fitness goals, and detect early signs of health issues, promoting proactive healthcare management and preventive interventions. Additionally, the COVID-19 pandemic has accelerated the adoption of remote monitoring solutions among healthcare consumers, further fuelling the growth of this category.

• Healthcare Providers
• Healthcare Consumers
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion